New Drugs and Clinical Trials Rules, 2019: The market trumps ethics and participant rights

A Journal of Healthcare Ethics & Humanities. Published since 1993 by Forum for Medical Ethics Society.
Peer-reviewed. Indexed in Medline, PubMed, The Philosopher’s Index, Scopus.

ISSN: 0975-5691 (Online); 0974-8466 (Print) RNI Reg No. MAHENG/2016/67188


Dublin Core		PKP Metadata Items	Metadata for this Document

1.	Title	Title of document	New Drugs and Clinical Trials Rules, 2019: The market trumps ethics and participant rights

2.	Creator	Author's name, affiliation, country	Amar Jesani; Independent Consultant Researcher and Teacher in Bioethics and Public Health, 31, Swatantrya Sainik Nagar, Andheri West, Mumbai 400 058; IN

3.	Subject	Discipline(s)

3.	Subject	Keyword(s)

4.	Description	Abstract	The enactment of the New Drugs and Clinical Trials Rules, 2019 (hereafter New Rules), on March 19 by the Ministry of Health and Family Welfare (MoHFW), Government of India (1), is the use of power delegated to the political executive by sub-section (1) of section 12 and sub-section (1) of section 33 of the Drugs and Cosmetics Act, 1940. Has this power been used wisely? Whose interests do these rules represent?

5.	Publisher	Organizing agency, location	Forum for Medical Ethics Society

6.	Contributor	Sponsor(s)

7.	Date	(YYYY-MM-DD)	2019-05-06

8.	Type	Status & genre

8.	Type	Type

9.	Format	File format	HTML , PDF

10.	Identifier	Uniform Resource Identifier	https://ijme.in/articles/new-drugs-and-clinical-trials-rules-2019-the-market-trumps-ethics-and-participant-rights/

11.	Source	Title; vol., no. (year)	Indian Journal of Medical Ethics;: Hope lies in informed struggle

12.	Language	English=en	en

13.	Relation	Supp. Files

14.	Coverage	Geo-spatial location, chronological period, research sample (gender, age, etc.)

15.	Rights	Copyright and permissions	All articles published in IJME are available on its website free of charge. The copyright for published material belongs to IJME/FMES. IJME freely permits the reprint (or reproduction on a website) of articles from the journal, as long as this is for non-commercial use and appropriate credit is given to the author and the journal and publication details are mentioned. The commercial use of our content can be made only after obtaining permission from and on payment to IJME. This is intended to support production of the journal.